Skip to content
Search

Latest Stories

Weight-loss injections can cause gallstones, warns pharmacist

An increasing number of patients taking weight-loss injections are having their gallbladders removed, the pharmacist said.

More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.


“I'm seeing more and more patients taking weight-loss injections who then need their gallbladders removed,” she said.

Grayson, known as The Godmother of Pharmacology, explained how these drugs increased the risk of gallstone formation.

“The injections slow down the flow of bile through the gallbladder and delay emptying by suppressing the release of the hormone that controls it.

“This is one of the key ways in which it works. Unfortunately, this can also mean that in some people, this can make bile more sludgy and even lead to the formation of gallstones,” she warned.

According to Grayson, the risk of gallstone development could be as high as 1 in 10 people taking these drugs.

Deborah Grayson LinkedIn

Eli Lilly has already acknowledged gallbladder-related side effects in its safety warnings for Mounjaro, which is an injectable prescription medicine originally developed to manage blood sugar in adults with type 2 diabetes.

It is also authorised for use in weight loss and weight management in adults aged 18 and over, alongside a reduced-calorie diet and increased physical activity.

“Gallbladder problems have happened in some people who use Mounjaro,” the company said.

The company also listed other serious potential side effects, including:

  • Thyroid tumors, including thyroid cancer
  • Pancreatitis (inflammation of the pancreas)
  • Hypoglycemia (low blood sugar)
  • Severe allergic reactions
  • Kidney failure
  • Serious stomach issues
  • Changes in vision

These problemshave also been associated with Wegovy (semaglutide), produced by Novo Nordisk.

Beware of the risk factors of gallstones

Grayson also highlighted other risk factors that could increase the risk of developing gallstones. These include being women, thyroid disease, menopausal or perimenopausal, and rapid weight loss.

“If any of these apply to you, it's important to look out for the signs that your gallbladder is struggling,” she said.

In a follow-up social media post, Grayson said that high cholesterol and poorly managed blood sugar are also risk factors and warned that “the more of these that apply the greater the risk.”

Symptoms of gallstones

Grayson advises patients taking the injections to be aware of the early warning signs of gallstones or sludgy bile that can lead to the stones forming. These include:

  • Acid reflux
  • Trapped wind and burping
  • Pain below the ribs
  • Left-sided shoulder pain
  • Abdominal pain
  • Diarrhoea or to a lesser extent constipation
  • Pale, greasy floaty stools
  • Bowel urgency

Patients experiencing these symptoms should seek medical advice promptly.

Before using weight loss jabs, it is advisable to inform your healthcare provider about any medical conditions you have and any medications you are taking to help prevent serious side effects.

More For You

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025

The Single Activity Fee (SAF) was increased by 19p to £1.46 per item, effective from April 2024.

gettyimages

19p SAF increase to be included in April and May 2025 advance payments

Following discussions with the Department of Health and Social Care (DHSC), Community Pharmacy England (CPE) has agreed a mechanism that will allow pharmacy owners to receive the 19p increase to the Single Activity Fee (SAF) earlier for the dispensing months of April and May 2025.

CPE said: “The advance payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance payments will be required from the June 2025 dispensing month onwards.”

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less